Free Trial

CASI Pharmaceuticals (CASI) Short Interest Ratio & Short Volume

CASI Pharmaceuticals logo
$1.40 -0.03 (-2.10%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CASI Pharmaceuticals Short Interest Data

CASI Pharmaceuticals (CASI) has a short interest of 30,300 shares, representing 0.77% of the float (the number of shares available for trading by the public). This marks a 131.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 48,958 shares to cover all short positions.

Current Short Interest
30,300 shares
Previous Short Interest
13,100 shares
Change Vs. Previous Month
+131.30%
Dollar Volume Sold Short
$35.75 thousand
Short Interest Ratio
0.3 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
12,299,000 shares
Float Size
3,920,000 shares
Short Percent of Float
0.77%
Today's Trading Volume
17,993 shares
Average Trading Volume
48,958 shares
Today's Volume Vs. Average
37%
Short Selling CASI Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for CASI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CASI Short Interest Over Time

CASI Days to Cover Over Time

CASI Percentage of Float Shorted Over Time

CASI Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202530,300 shares $35.75 thousand +131.3%0.8%0.3 $1.18
6/15/202513,100 shares $24.10 thousand -35.8%0.3%0.1 $1.84
5/31/202520,400 shares $38.96 thousand +20.7%0.5%2.1 $1.91
5/15/202516,900 shares $30.59 thousand +62.5%0.3%1.8 $1.81
4/30/202510,400 shares $20.18 thousand -46.9%0.2%1.1 $1.94
4/15/202519,600 shares $38.04 thousand +2.6%0.4%1.6 $1.94
3/31/202519,100 shares $41.26 thousand -18.0%0.4%1.3 $2.16
3/15/202523,300 shares $51.35 thousand -15.0%0.5%1.1 $2.20
2/28/202527,400 shares $61.65 thousand -24.1%0.6%0.9 $2.25
2/15/202536,100 shares $90.25 thousand -2.7%0.8%1 $2.50
1/31/202537,100 shares $91.64 thousand +17.0%0.8%1 $2.47
1/15/202531,700 shares $80.52 thousand -48.0%0.8%0.7 $2.54
12/31/202461,000 shares $172.63 thousand +43.5%1.6%1.3 $2.83
12/15/202442,500 shares $132.18 thousand -4.9%1.1%1 $3.11
11/30/202444,700 shares $169.86 thousand -0.5%1.2%1.2 $3.80
11/15/202444,900 shares $239.32 thousand -40.6%1.2%1.5 $5.33
10/31/202475,600 shares $452.84 thousand -31.3%1.9%2.8 $5.99
10/15/2024110,000 shares $613.80 thousand -24.9%2.6%4.1 $5.58
9/30/2024146,500 shares $873.14 thousand -9.4%3.4%4.3 $5.96
9/15/2024161,700 shares $1.16 million -2.9%3.8%0.7 $7.17
8/31/2024166,600 shares $1.10 million -3.1%3.9%0.7 $6.59
8/15/2024172,000 shares $1.13 million -15.1%4.0%0.7 $6.56
7/31/2024202,600 shares $1.47 million -6.9%3.2%0.8 $7.25
7/15/2024217,600 shares $1.36 million -58.9%3.4%0.9 $6.25
6/30/2024529,600 shares $2.91 million +771.1%8.2%2.3 $5.50
6/15/202460,800 shares $189.09 thousand -23.7%0.9%1.1 $3.11
5/31/202479,700 shares $307.96 thousand +50.1%1.3%2 $3.86
5/15/202453,100 shares $180.01 thousand +14.7%0.8%0.3 $3.39
4/30/202446,300 shares $106.49 thousand -25.9%0.7%0.2 $2.30
4/15/202462,500 shares $153.13 thousand -24.0%1.0%0.3 $2.45
3/31/202482,200 shares $296.74 thousand -35.4%1.3%0.4 $3.61
3/15/2024127,300 shares $404.81 thousand +204.6%2.2%0.7 $3.18
2/29/202441,800 shares $233.66 thousand -21.3%0.7%0.2 $5.59
2/15/202453,100 shares $323.38 thousand +0.8%0.9%1.1 $6.09
1/31/202452,700 shares $361.52 thousand +10.0%0.9%1 $6.86
1/15/202447,900 shares $291.23 thousand +74.8%0.8%0.9 $6.08
12/31/202327,400 shares $196.18 thousand -18.7%0.5%0.5 $7.16
12/15/202333,700 shares $206.58 thousand -58.4%0.6%0.6 $6.13
11/30/202381,000 shares $452.79 thousand -46.4%1.4%1.9 $5.59
11/15/2023151,200 shares $657.72 thousand -33.0%2.5%4.9 $4.35
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
10/31/2023225,700 shares $911.83 thousand +0.6%3.4%9 $4.04
10/15/2023224,400 shares $587.93 thousand -2.6%3.4%12 $2.62
9/30/2023230,400 shares $589.82 thousand -1.5%3.5%15.8 $2.56
9/15/2023233,900 shares $493.53 thousand -1.6%3.5%22.1 $2.11
8/31/2023237,600 shares $548.86 thousand -1.4%3.6%9.1 $2.31
8/15/2023241,000 shares $535.02 thousand +2.4%3.6%8.1 $2.22
7/31/2023235,300 shares $571.78 thousand -3.6%3.5%7.7 $2.43
7/15/2023244,100 shares $646.87 thousand -2.6%3.7%8.2 $2.65
6/30/2023250,700 shares $624.24 thousand -7.4%3.8%6.9 $2.49
6/15/2023270,800 shares $557.85 thousand +12.6%4.1%5.2 $2.06
5/31/2023240,500 shares $678.21 thousand -5.1%3.4%6.5 $2.82
5/15/2023253,300 shares $640.65 thousand -0.7%3.6%7.3 $2.53
4/30/2023255,200 shares $730.38 thousand -5.0%3.6%7.3 $2.86
4/15/2023268,700 shares $964.63 thousand +6.5%3.6%7.1 $3.59
3/31/2023252,200 shares $585.10 thousand +3.4%2.7%6.4 $2.32
3/15/2023244,000 shares $417.24 thousand -6.1%2.6%9.1 $1.71
2/28/2023259,700 shares $501.22 thousand -1.7%2.8%8.3 $1.93
2/15/2023264,300 shares $509.78 thousand +0.9%2.2%8 $1.93
1/31/2023262,000 shares $534.48 thousand -5.7%2.0%7.8 $2.04
1/15/2023277,800 shares $548.66 thousand -5.9%2.1%8.2 $1.98
12/30/2022295,200 shares $528.41 thousand +44.1%2.3%8.7 $1.79
12/15/2022204,900 shares $370.87 thousand +77.6%1.6%5.5 $1.81
11/30/2022115,400 shares $229.65 thousand +27.4%0.9%2.6 $1.99
11/15/202290,600 shares $176.67 thousand -13.6%0.7%1.6 $1.95
10/31/2022104,900 shares $206.65 thousand -9.6%1.0%0.6 $1.97
10/15/2022116,000 shares $257.52 thousand +26.2%1.1%0.6 $2.22
9/30/202291,900 shares $238.94 thousand -41.5%0.9%0.4 $2.60
9/15/2022157,200 shares $664.96 thousand +28.9%1.5%0.7 $4.23
8/31/2022122,000 shares $457.50 thousand -57.1%1.2%0.6 $3.75
8/15/2022284,500 shares $1.14 million +94.5%2.7%1.3 $4.02
7/31/2022146,300 shares $361.36 thousand -18.8%1.4%1.5 $2.47
7/15/2022180,100 shares $491.67 thousand -14.9%1.7%2.5 $2.73
6/30/2022211,700 shares $605.46 thousand +28.9%2.0%3.1 $2.86
6/15/2022164,300 shares $509.33 thousand +89.9%1.8%2.4 $3.10
5/31/202286,500 shares $297.56 thousand -85.9%N/A1.4 $3.44
5/15/2022612,700 shares $213.53 thousand +2.1%0.7%1.8 $0.35
4/30/2022600,200 shares $258.09 thousand -5.2%0.7%1.5 $0.43
4/15/2022633,400 shares $393.34 thousand -26.7%0.7%1.3 $0.62
3/31/2022863,900 shares $699.50 thousand -10.8%1.0%1.4 $0.81
3/15/2022968,800 shares $773.97 thousand -19.3%1.1%1.5 $0.80
2/28/20221,200,000 shares $1.01 million -4.0%1.4%1.6 $0.84
2/15/20221,250,000 shares $1.02 million -22.4%1.4%1.4 $0.82
1/31/20221,610,000 shares $1.08 million +1.9%1.8%1.4 $0.67
1/15/20221,580,000 shares $1.14 million -25.8%N/A1.3 $0.72
12/31/20212,130,000 shares $1.70 million -9.4%2.4%1.7 $0.80
12/15/20212,350,000 shares $1.89 million -27.5%2.7%1.6 $0.80
11/30/20213,240,000 shares $2.90 million +14.5%3.7%1.4 $0.90
11/15/20212,830,000 shares $2.89 million -8.7%3.2%1.2 $1.02
10/29/20213,100,000 shares $3.35 million +12.3%3.5%1.2 $1.08
10/15/20212,760,000 shares $3.17 million +11.7%3.1%1.1 $1.15
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
9/30/20212,470,000 shares $2.94 million -10.5%2.8%1.1 $1.19
9/15/20212,760,000 shares $4.08 million -34.1%3.1%1.3 $1.48
8/31/20214,190,000 shares $6.70 million +28.9%4.7%3.1 $1.60
8/13/20213,250,000 shares $4.26 million +5.5%3.7%2.6 $1.31
7/30/20213,080,000 shares $3.57 million -2.2%3.5%3.4 $1.16
7/15/20213,150,000 shares $4.22 million -2.8%3.5%2.3 $1.34
6/30/20213,240,000 shares $5.02 million -40.1%3.6%2.2 $1.55
6/15/20215,410,000 shares $8.93 million +1.5%6.1%2.6 $1.65
5/28/20215,330,000 shares $8.53 million +24.0%6.0%2.7 $1.60
5/14/20214,300,000 shares $6.11 million +24.3%4.8%2.3 $1.42
4/30/20213,460,000 shares $6.26 million +52.4%3.9%1.9 $1.81
4/15/20212,270,000 shares $4.27 million +8.6%2.7%1.6 $1.88
3/31/20212,090,000 shares $4.16 million +22.9%2.7%1.7 $1.99
3/15/20211,700,000 shares $4.22 million -3.4%2.3%3.3 $2.48
2/26/20211,760,000 shares $4.38 million +6.7%2.4%3.7 $2.49
2/12/20211,650,000 shares $4.95 million -9.8%2.3%3.2 $3.00
1/29/20211,830,000 shares $6.28 million +2.2%2.5%3.9 $3.43
1/15/20211,790,000 shares $5.96 million -3.2%2.5%3.3 $3.33
12/31/20201,850,000 shares $5.48 million -2.1%2.6%4 $2.96
12/15/20201,890,000 shares $4.59 million +1.6%2.6%4.4 $2.43
11/30/20201,860,000 shares $4.50 million +1.1%2.6%4.7 $2.42
11/15/20201,840,000 shares $3.64 million +4.0%2.5%4.8 $1.98
10/30/20201,770,000 shares $3.42 million +22.1%2.4%4.4 $1.93
10/15/20201,450,000 shares $2.48 million -6.5%2.0%3.4 $1.71
9/30/20201,550,000 shares $2.37 million +0.7%2.1%3.1 $1.53
9/15/20201,540,000 shares $2.62 million +19.4%2.1%3.1 $1.70
8/31/20201,290,000 shares $2.21 million -9.8%1.8%2.8 $1.71
8/14/20201,430,000 shares $2.75 million -21.4%2.3%3.3 $1.92
7/31/20201,820,000 shares $3.51 million +9.6%3.8%4.2 $1.93
7/15/20201,660,000 shares $3.49 million -3.5%3.1%6 $2.10

CASI Short Interest - Frequently Asked Questions

What is CASI Pharmaceuticals' current short interest?

Short interest is the volume of CASI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 30,300 shares of CASI short. 0.77% of CASI Pharmaceuticals' shares are currently sold short. Learn More on CASI Pharmaceuticals' current short interest.

Which institutional investors are shorting CASI Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CASI Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for CASI Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.77% of CASI Pharmaceuticals' floating shares are currently sold short.

Is CASI Pharmaceuticals' short interest increasing or decreasing?

CASI Pharmaceuticals saw a increase in short interest in June. As of June 30th, there was short interest totaling 30,300 shares, an increase of 131.3% from the previous total of 13,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is CASI Pharmaceuticals' float size?

CASI Pharmaceuticals currently has issued a total of 12,299,000 shares. Some of CASI Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CASI Pharmaceuticals currently has a public float of 3,920,000 shares.

How does CASI Pharmaceuticals' short interest compare to its competitors?

0.77% of CASI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CASI Pharmaceuticals: Alto Neuroscience, Inc. (9.35%), Clearside Biomedical, Inc. (0.54%), Assertio Holdings, Inc. (6.37%), Metagenomi, Inc. (6.79%), Biomea Fusion, Inc. (17.22%), PMV Pharmaceuticals, Inc. (2.14%), Repare Therapeutics Inc. (2.05%), MediciNova, Inc. (0.36%), Achilles Therapeutics plc (1.26%), PDS Biotechnology Corporation (6.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short CASI Pharmaceuticals stock?

Short selling CASI is an investing strategy that aims to generate trading profit from CASI Pharmaceuticals as its price is falling. CASI shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CASI Pharmaceuticals?

A short squeeze for CASI Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CASI, which in turn drives the price of the stock up even further.

How often is CASI Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CASI, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:CASI) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners